A 31-year-old female patient with concurrent clinical onset of multiple sclerosis and COVID-19 : Possible role of SARS-CoV-2 in the pathogenesis of multiple sclerosis
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:20 |
|---|---|
| Enthalten in: |
Autoimmunity reviews - 20(2021), 5 vom: 01. Mai, Seite 102803 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Naser Moghadasi, Abdorreza [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
Date Completed 23.04.2021 Date Revised 23.04.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.autrev.2021.102803 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM322935938 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM322935938 | ||
| 003 | DE-627 | ||
| 005 | 20231225183109.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.autrev.2021.102803 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1076.xml |
| 035 | |a (DE-627)NLM322935938 | ||
| 035 | |a (NLM)33737090 | ||
| 035 | |a (PII)S1568-9972(21)00067-7 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Naser Moghadasi, Abdorreza |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A 31-year-old female patient with concurrent clinical onset of multiple sclerosis and COVID-19 |b Possible role of SARS-CoV-2 in the pathogenesis of multiple sclerosis |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 23.04.2021 | ||
| 500 | |a Date Revised 23.04.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Letter | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Immune response | |
| 650 | 4 | |a Multiple sclerosis | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 7 | |a Immunosuppressive Agents |2 NLM | |
| 773 | 0 | 8 | |i Enthalten in |t Autoimmunity reviews |d 2002 |g 20(2021), 5 vom: 01. Mai, Seite 102803 |w (DE-627)NLM126096996 |x 1873-0183 |7 nnns |
| 773 | 1 | 8 | |g volume:20 |g year:2021 |g number:5 |g day:01 |g month:05 |g pages:102803 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.autrev.2021.102803 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 20 |j 2021 |e 5 |b 01 |c 05 |h 102803 | ||